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Abstract 
 
Background : Neurotrophins are important regulators for neural development and 
regeneration. Nerve growth factor (NGF) therapy has been tested in various models of neural 
injury and degeneration. However, whether NGF can reach target tissues and maintain 
effective concentration for a certain period of time remains uncertain. To facilitate neural 
regeneration, we investigate the possibility of combining NGF and electrical stimulation (ES) 
in promoting neurite outgrowth, an essential process during neural regeneration. 
Methods : PC12 cells were seeded on collagen and indium tin oxide (ITO)-coated area on the 
transparent conductive devices. Cells were then subjected to the combination of ES and NGF 
treatment. Neurite outgrowth was compared. 
Results : Our findings suggest that ES of 100 mV/mm together with NGF provides optimal 
effect on neurite outgrowth of PC12 cells. ES increases NGF-induced neurite length but 
reduces neurite branching, indicative of its primary effect on neurite elongation instead of 
initiation. One mechanism that ES enhances neurite outgrowth is through increasing 
NGF-induced phosphorylation of ERK1/2 (pERK1/2) and expression of Egr1 gene. ES has 
previously been demonstrated to increase the activity of protein kinase C (PKC). Our result 
indicates that activating PKC further increases NGF-induced pERK1/2 and thus neurite 
outgrowth. 
Conclusion : It is likely that ES promotes NGF-induced neurite outgrowth through 
modulating the activity of ERK1/2. 
General significance : Findings from this study suggest that combining ES and NGF provides 
a promising strategy for promoting neurite outgrowth. 
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1. Introduction 
 
In response to nerve injury, a series of cellular events are induced, including signaling 
from damaged site, recruitment of macrophage, increased synthesis of neurotrophins and 
regeneration of nerve fibers. To regenerate damaged or degenerating neurons, inducing 
neuronal differentiation and maintaining neuronal survival are essential processes. During 
neuronal differentiation, neurite outgrowth is an early and essential process. Various 
pharmacological treatments have been used to induce neurite outgrowth — one of these is the 
use of neurotrophins [1-5]. Neurotrophins are a family of closely related proteins that regulate 
many aspects of development, survival, maintenance and function of neurons. For a subset of 
neurons, including sympathetic neurons, nerve growth factor (NGF) is the main neurotrophin 
that induces neurite outgrowth and is required for the maintenance of neuronal phenotype. 
Upon binding to its cell surface receptor TrkA, NGF–TrkA complexes initiate the 
transmission of extracellular cues to intracellular signaling pathways and eventually turn on 
genes required for neuronal differentiation. These signaling pathways include activation of 
mitogen-activated protein kinase (MAPK) cascades, phosphatidyl inositol-3-kinase (PI3K) 
stimulation of AKT and phospholipase C γ (PLCγ)-dependent generation of inositol 
triphosphate (IP3) and diacylglycerol (DAG) resulting in mobilization of Ca2 + stores and 
activation of Ca2 +-responsive proteins. Extracellular signal-regulated kinase 1/2 (ERK1/2) 
belongs to MAPK family [6-10]. In response to NGF stimulation, ERK1/2 is phosphorylated 
by MEK (MAPK kinase) leading to induction of genes responsible for various cellular 
functions, including cell proliferation, differentiation and migration. Meanwhile, 
NGF-induced phosphorylation of PI3K results in increased AKT activity which has been 
well-documented to affect neuronal survival. More recently, AKT has also been regarded as 
an important mediator of several aspects of neurite outgrowth, including elongation, 
branching and caliber. Based on the positive effects of NGF on neurite outgrowth and 
survival, various animal studies and clinical trials of NGF therapy for nerve injury and 
neurodegenerative diseases have been initiated [11-14]. 
 
Another venue to promote neurite outgrowth is through electrical stimulation (ES), 
which also represents a less-invasive or non-invasive approach. A number of in vivo and in 
vitro studies have shown promise of ES in neurite extension and regeneration of transected 
nerve ends [15-19]. Although the exact mechanisms by which ES enhances nerve 
regeneration are not well understood, some cellular responses induced by ES have been 
reported. These responses include neurite outgrowth, induction of neuronal tubulin, 
neurofilament 200, and c-fos gene expression  [16, 20]. Activation of protein kinase C (PKC) 
and Ca2 +mobilization are shown to be early response by ES [21-29]. However, it remains to 
be determined exactly what signaling pathways are initiated and are responsible for neurite 
outgrowth by ES. 
 
While most of the data support a positive role of NGF in neurite outgrowth, the 
concentration gradient of applied NGF may exert adverse effect on other cell types. Moreover, 
local NGF treatment is not optimal for long-range regeneration of damaged nerve and long 
period of treatment using NGF raises an issue of medical cost [3-5,30-33] . Thus, 
investigating combination of NGF therapy with other approach to promote neurite outgrowth 
is of great interest. In this study, we examine whether ES would corroborate with NGF to 
promote neurite outgrowth of PC12 cells. We also determine whether different strengths of 
ES would affect NGF-induced neurite initiation, elongation and branching using PC12 cells 
as a model system. PC12 cell line is established as a noradrenergic clonal cell line that can be 
differentiated into sympathetic neurons in response to NGF [34]. We further examine the 
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possibility that ES-activated pathways may converge with NGF-induced signaling pathways 
to promote neurite outgrowth. 
 
 
2. Material and methods 
 
2.1. Reagents 
 
Anti-ERK1/2 and bovine serum albumin (BSA), phorbol 12-myristate 13 acetate (PMA) 
and chelerythrine were purchased from Sigma (S. Louis, MO). Anti-pERK1/2(Thr202, 
Tyr204), anti-AKT, anti-pAKT(S473), anti-pSTAT3(S727), and anti-STAT3 were purchased 
from form Cell Signaling (Danvers, MA). Anti-Egr1 was purchased from Santa Cruz 
Biotechnology (Santa Cruz, CA). IRDye800W-labeled anti-rabbit secondary antibody was 
from LI-COR Biosciences (Lincoln, NE). Alexa Fluor 700 goat anti-mouse secondary 
antibody, Alexa Fluor 488 secondary antibody, and rhodamine phalloidin were from 
Invitrogen (Carlsbad, CA). NGF and rat-tail collagen I were purchased from BD Bioscience 
(Bedford, MA). Anti-neuronal tubulin (Tuj1) antibody was purchased from Covance 
(Richmond, CA). Protein Assay Kit (Cat# PAK500) was purchased from Strong Biotech 
Corporation, Taiwan. Paraformaldehyde (PFA) 16% was purchased from Electron 
Microscopy Sciences. 
 
 
2.2. Cell culture 
 
The PC12 cells were purchased from American Type Culture Collection. PC12 cells 
were seeded on the collagen-coated dish (coated with 0.1 mg/ml rat-tail collagen in 0.02 N 
acetic acid) and maintained in complete medium, DMEM supplemented with 10% 
heat-inactivated horse serum (HS), 5% fetal bovine serum (FBS), 1% l-glutamine (L-Gln) 
and 1% antibiotic–antimycotic (AA) (Invitrogen) under 10% CO2 at 37 °C condition. Before 
treatment of NGF or ES, cells were deprived in serum-free media for 8 to 16 h. The 
serum-free media was the DMEM supplemented with 1% BSA, 1% L-Gln and 1% AA. 
 
 
2.3. Electrical stimulation and microscopy 
 
ES was performed by using transparent conductive devices designed and manufactured 
in Department of Electrical Engineering, National Tsing Hua University. The electrodes were 
fabricated on borosilicate glass to facilitate observation with an inverted microscope. Indium 
tin oxide (ITO) of 0.1 μm in thickness was deposited by radio frequency (RF) sputtering and 
patterned by the lift-off technique to form electrodes separated by 2 mm. Metal wires were 
then glued to the pads by silver paste. The bio-compatible polydimethylsiloxane (PDMS) was 
used to attach the glass chip in a 3.5-cm Petri dish and reinforce the wire connection. PDMS 
was used because of its low toxicity to cells. To evaluate neurite outgrowth, various 
amplitudes of ES were applied to cells via a function generator (Agilent Technologies, Taipei, 
Taiwan). 
 
PC12 cells were seeded on collagen and ITO-coated area on the chips and maintained 
in complete medium 24 h. After 24 h, cells were deprived in serum-free medium for 
overnight. PC12 cells were subjected to sinusoidal stimulation potential of 100 mV, 200 mV 
or 400 mV alternating current, peak-to-peak, with a frequency of 100 Hz for 2 h, followed by 
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the addition of NGF. The distance of two electrodes was 2 mm, so the electric field generated 
was 50, 100 or 200 mV/mm. Images were taken using Carl Zeiss Observer Z1 microscope. 
Neurite length of PC12 cells was measured using ImageJ software. The longest neurite of 
each cell was compared. The definition of attachment point is the number of neurites 
connected to the soma and the endpoint is the number of the neurite tips. 
 
 
2.4. Immunoblotting 
 
Cell lysates were collected in RIPA buffer (50 mM Tris, pH 7.5, 1% Triton X-100, 
150 mM NaCl, 2 mM EGTA) containing with 1 mM Na3VO4, 1 mM 
phenylmethanesulphonyl fluoride (PMSF), 10 ng/ml aprotinin and 10 ng/ml leupeptin. 
Protein concentration of each sample was determined by protein assay kit using Bradford 
method. The samples with equal amount of protein were separated by sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotted with the 
indicated antibodies. The immunoblots were subsequently detected using IRDye-conjugated 
IgG and the Odyssey Infrared Imaging System. 
 
 
2.5. Immunofluorescence staining 
 
Cells were treated without or with ES and fixed by 4% paraformaldehyde, 
permeabilized by 0.1% of Triton X-100, and incubated with anti-neuronal tubulin (Tuj1) 
antibodies, followed by incubation with the Alexa Fluor 488 secondary antibody, rhodamine 
phalloidin (for actin visualization) and DAPI (for visualizing the nucleus). Images were taken 
using Carl Zeiss Observer Z1 microscope. 
 
 
2.6. Statistical analysis 
 
The statistical analysis of differentiation percentage, attachment points, endpoints and 
immunoblotting quantification were performed using one-way ANOVA. Significance (*) is 
defined as P < 0.05. 
 
 
3. Results and discussion 
 
3.1. Electrical stimulation is not sufficient to induce neurite outgrowth 
 
ES has previously been suggested to induce cellular protrusion/process or neurite 
outgrowth of PC12 cells[20,35]. We re-visited the effect of ES on neurite outgrowth. To this 
end, we have designed a transparent indium tin oxide (ITO) conductive device with 
electrodes of 2 mm apart on a borosilicate glass placing in culture dishes (see Materials and 
methods) for growing cells and imaging live cells using inverted microscope (Fig. 1A). ITO 
was used because of its electrical conductivity and it can be deposited as a thin film for 
convenient electrode design. To determine whether ES could induce neurite outgrowth of 
PC12 cells, PC12 cells were seeded on collaged-coated ITO chip dishes then treated with or 
without ES of 100 mV/mm for 2–3 days (Fig. 1B–C). As shown in Fig. 1B, ES alone was not 
sufficient to induce neurite outgrowth of PC12 cells. Morphologically, some cells had more 
spikes than others, but these cellular protrusions/processes/filopodia are not necessary 
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neurites. To form stable neurites, the length of neurites needs to be at least the diameter of 
cell body. Morphological spikes of less than one cell body (small filopodia-like protrusion of 
cellular process) cannot be considered as neurites. Nonetheless, actin-rich filopodia are 
known to precede the formation of neurites [36,37]. Using rhodamine phalloidin staining to 
label actin, filopodia were identified. As shown in Fig. 1D, we did not find ES of 
100 mV/mm affect filopodia or neurite outgrowth of PC12 cells. 
 
 
 
 
Fig. 1. Electrical stimulation alone is not sufficient to induce neurite outgrowth of PC12 cells. (A) Diagram of 
designed ITO chip for ES. Indium tin oxide (ITO) electrodes of 0.1 μm in thickness were separated by 2 mm 
and coated on glass. ES was performed by using transparent electrodes fabricated on glass substrates to facilitate 
observation with an inverted microscope. Cells were cultured on ITO-coated area. (B) PC12 cells were treated 
without (−) or with (+) electric field of 100 mV/mm for 0–2 days. Live cell images are shown. Dark shaded area 
is ITO-coated. (C) PC12 cells were treated without (−) or with (+) 100 mV/mm ES for 3 days. Live cell images 
are shown. (D) Cells were treated as in (C), fixed and incubated with rhodamine phalloidin to visualize actin 
filaments. Red arrows indicate filopodia. 
 
 
 
3.2. Effect of electrical stimulation enhances NGF-induced neurite outgrowth 
 
NGF is known to induce neuronal differentiation of PC12 cells. We next determined 
whether ES would affect NGF-induced neurite outgrowth during differentiation of PC12 cells. 
From our previous experience, NGF exerts its effects very fast. To avoid effect of ES masked 
by NGF action, we subjected cells to ES 2 h before the addition of NGF to culture medium in 
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the following experiments. PC12 cells were electrically stimulated with 50 mV/mm for 2 h 
before adding 100 ng/ml NGF for 22 h with continuous ES. As a control, cells were treated 
with NGF without ES for 22 h (Fig. 2A, left panel). For measurement purpose, we define the 
diameter of cell body as D, and compared percentages of cells with neurites, cells with 
neurite length between 1 and 2 times (1–2xD) the diameter of cell body, and cells with 
neurites at least twice the diameter of cell body (> 2xD) (Fig. 2A, right panel). As shown 
in Fig. 2B, 50 mV/mm ES did not enhance 100 ng/ml NGF-induced neurite outgrowth. There 
is no difference in turns of percentages of cell population with different neurite lengths 
(Fig. 2C). Longer treatment of 48 or 72 h stimulation was performed with similar results 
(Fig. 2D). This finding suggests that 50 mV/mm ES is not capable of enhancing 
NGF-induced neurite outgrowth. 
 
 
 
 
Fig. 2. 50 mV/mm electrical stimulation did not enhance NGF-induced neurite outgrowth. (A) PC12 cells were 
subjected to 50 mV/mm ES for 2 h before adding 100 ng/ml NGF for additional 22 h. As a control, PC12 cells 
were treated with 100 ng/ml NGF for 22 h. (B) Percentages of cells bearing filopodia (short protrusion or 
process) or neurites are shown. (C) Percentage of cells with various lengths of neurites (1–2xD or > 2xD) is 
compared. 400–550 cells were counted per experiment. Values are mean ± S.E.M. from four independent 
experiments. (D) PC12 cells were subjected to 50 mV/mm ES for 2 h before adding 100 ng/ml NGF. Percentage 
of cells with neurite length of 1–2xD or > 2xD is compared. 800–900 cells were counted per experiment. Cells 
were fixed and incubated with rhodamine phalloidin to visualize actin filaments (red), DAPI to visualize the 
nucleus (blue) or anti-neuronal tubulin (Tuj1) antibody followed by Alexa Fluor 488 secondary antibody (green) 
for immunofluorescence staining. 
 
 
We next examine whether stronger ES would enhance NGF-induced neurite outgrowth 
of PC12 cells. PC12 cells were stimulated with 100 mV/mm for 2 h before 100 ng/ml NGF 
addition and continuous ES for 22 or 46 h (Fig. 3A). NGF + ES for 22 h (Fig. 3B, left panel) 
did not affect the percentages of cells with neurites, whereas NGF + ES for 46 h enhanced 
percentages of cells with neurites (Fig. 3B, right panel). The averaged neurite length of cells 
treated with NGF for 46 h was 76 μm, whereas it was 110 μm with combined treatment of 
NGF and ES (Fig. 3C). To understand whether ES affects the number of primary neurites or 
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neurite branches, the numbers of attachment points and endpoints were measured and 
counted as depicted in the right panel of Fig. 3A. Interestingly, the numbers of attachment 
points were reduced 17% and endpoints were reduced 24% with 100 mV/mm ES (Fig. 3D–E). 
Attachment points represent the number of primary neurites extending from soma. Number of 
endpoints infers to the degree of neurite branching. These two parameters were consistently 
reduced with ES suggesting that 100 mV/mm enhances neurite elongation instead of 
initiation. This finding also echoes the result from Fig. 1 that ES alone is not sufficient to 
initiate neurites. Only when NGF induces neurite initiation, could ES enhance neurite 
elongation. 
 
 
 
 
Fig. 3. 100 mV/mm electrical stimulation enhances NGF-induced neurite elongation 
of PC12 cells. (A) PC12 cells were subjected to 100 mV/mm ES 2 h before adding 
100 ng/ml NGF for 22 or 46 h. As a control, PC12 cells were treated with 100 ng/ml 
NGF for 22 or 46 h. Neurite length was calculated and compared. Attachment points 
and endpoints were counted. (B) Percentages of cells with neurite length of 1–2xD or 
> 2xD in either condition were calculated. 600–900 cells were counted per experiment. 
Values are mean ± S.E.M. from four independent experiments. Averaged neurite length 
(C), attachment points (D) and endpoints (E) per cell were measured from three 
independent experiments. 70–100 cells were counted per experiment. Values are 
mean ± S.E.M. (*: P < 0.05, one-way ANOVA). 
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One of the problems of NGF therapy in animal studies is the non-target effect of NGF. 
Reducing concentration of NGF may be beneficial in this regard if higher ES can compensate 
the trophic effect of NGF. To this end, PC12 cells were stimulated with 50, 100 or 
200 mV/mm for 2 h followed by 50 ng/ml NGF treatment with continuous ES for 22 or 46 h. 
When cells were treated with 50 ng/ml NGF, applying either 50 or 100 mV/mm ES for 22 or 
46 h did not result in significant difference of neurite outgrowth (Supplemental Fig. 1S). 
Combination of 50 ng/ml NGF and ES of 200 mV/mm, on the other hand, enhanced the 
percentages of PC12 cells with neurites (Fig. 4B). The percentage of cells with 1–2xD or 
> 2xD neurites was increased by ES (Fig. 4C). Averaged neurite length increased 56% with 
ES compared to control (Fig. 4D). The reduction of attachment points and endpoints was 
similar to those treated with 100 mV/mm and 100 ng/ml NGF (Figs. 4E–F and 3D–E). 
 
Results from Fig. 3 showed that 100 mV/mm ES increased NGF-induced neurite length 
approximately 45% (Fig. 3). When NGF concentration was reduced to 50 ng/ml and together 
with 200 mV/mm stimulation, neurite length increased 56% (Fig. 4). These findings seem to 
suggest that increasing the strength of ES further increases neurite elongation. However, 
overall neurite length and percentages of cells with neurites under 200 mV/mm and 50 ng/ml 
NGF are not better than the condition of 100 mV/mm and 100 ng/ml NGF (Fig. 3-4). This 
result could potentially due to cellular toxicity caused by 200 mV/mm stimulation. 
 
 
 
 
Fig. 4. 200 mV/mm electrical stimulation enhances NGF-induced neurite length, reduces attachment points and 
endpoints. (A) PC12 cells were subjected to 200 mV/mm ES for 2 h before adding 50 ng/ml NGF for 22 or 46 h. 
As a control, PC12 cells were treated with 50 ng/ml NGF for 22 or 46 h. (B) Representative live cell images of 2 
and 48 h stimulated cells are shown. (C) Percentages of cells with neurite length of 1–2xD or > 2xD in each 
condition were calculated. 350–500 cells were counted per experiment. Averaged neurite length (D), attachment 
points (E) and endpoints (F) per cell were measured from three independent experiments. 70–100 cells were 
counted per experiment. Values are mean ± S.E.M. (*: P < 0.05, one-way ANOVA). 
9 
 
3.3. Electrical stimulation enhances NGF-induced pERK1/2 level 
 
Several signaling pathways are implicated in NGF-induced neuronal differentiation of 
PC12 cells, including MEK–ERK1/2, PI3K–AKT pathways, and pathways involve activation 
of PLCγ, PKC and signal transducers and activators of transcription-3 (STAT3) [38]. To 
determine whether ES modulates any of these pathways, PC12 cells were treated with or 
without ES with 50 mV/mm for 2 h followed by NGF treatment (Fig. 5A). Phosphorylations 
of ERK1/2, AKT and STAT3 were examined via western blotting. As shown in Fig. 5B–C, 
ES enhanced NGF-induced pERK1/2 level approximately 40% but did not change 
pSTAT3(S727) and pAKT(S473) levels, compared to those without ES. This result raises a 
possibility that ES may enhance NGF-induced neuronal differentiation through regulating 
MEK–ERK1/2 pathway. We thus examined whether different amplitudes of ES differentially 
affects MEK–ERK1/2 pathway. To this end, PC12 cells were stimulated with 0, 50 or 
100 mV/mm for 2 h before NGF addition for 22 h. As shown in Fig. 5D, 50 mV/mm ES 
increased 40%, whereas 100 mV/mm ES increased 70%, of NGF-induced pERK1/2 level 
compared to no ES controls. Similarly, PC12 cells subjected to 200 mV/mm stimulation also 
increased NGF-induced pERK1/2 level compared to no ES controls (Fig. 5D, right panels). 
Moreover, 100 mV/mm ES enhanced NGF-induced expression of early growth response 
protein 1 (Egr1), a downstream effector of MEK–ERK1/2 pathway (Fig. 5E). Taken together, 
these results provide important insights that ES synergistically enhances NGF-induced 
MEK/ERK1/2–Egr1 pathway to promote neurite outgrowth. 
 
ES has previously been suggested to regulate neurite outgrowth through regulating 
PKC activity [21,22]. To investigate whether activating PKC would synergistically promote 
NGF-induced pERK1/2, PC12 cells were pretreated with or without PKC activator, PMA, 
followed by the addition of NGF. As shown in Fig. 6A, activating PKC enhanced 
NGF-induced pERK1/2 level more than 2-fold. Consistent with a previous study showing 
that PKC inhibitor blocked the effect of ES but not NGF [20], our result also showed that 
treating cells with PKC inhibitor, chelerythrine, did not affect NGF-induced pERK1/2 
(Fig. 6B). It is thus likely that ES activates PKC to enhance NGF-induced MEK–ERK1/2 
signaling, gene expression and thus neurite outgrowth (Fig. 6C). 
 
 
4. Conclusion 
 
In this study, we explore the strategy of combining NGF and ES on promoting neurite 
outgrowth. Our results demonstrate that ES promotes NGF-induced neurite elongation. 
Among the conditions we have tested, combining 100 mV/mm ES and 100 ng/ml NGF 
provides the optimal effect on neurite outgrowth and percentage of cells with neurites (Fig. 3). 
We further demonstrate that ES enhances NGF-induced signaling and gene expression, 
specifically MEK–ERK1/2 pathway and Egr1 expression (Fig. 5). While ES robustly 
activates PKC as suggested by several studies [21,22], we find that activation of PKC leads to 
enhancement of NGF-induced pERK1/2. These findings provide important insights into how 
ES may regulate NGF-induced signaling and gene expression to promote neurite outgrowth. 
The protocol used in this study could potentially be considered for treatment of 
neurodegeneration or nerve injury. 
 
 
Supplementary data to this article can be found online at http://dx.doi.org/10. 
1016/j.bbagen.2013.04.007. 
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Fig. 5. Electrical stimulation enhances NGF-induced 
pERK1/2. (A) PC12 cells were subjected to 
50 mV/mm ES for 2 h before adding 100 ng/ml 
NGF for 22 h with continuous ES. As a control, 
PC12 cells were treated with 100 ng/ml NGF for 
22 h. (B) Cells were treated as in (A), cell lysates 
were collected and equal amount of proteins was 
separated by SDS-PAGE and immunoblotted with 
anti-pERK1/2, ERK1/2, pSTAT3(S727), STAT3, 
pAKT(S473) and AKT antibodies. Representative 
blots are shown from three independent experiments. 
(C) Relative levels of pERK1/2, pSTAT3(S727) and 
pAKT(S473) were normalized to total ERK1/2, 
STAT3, and AKT levels and compared to NGF only 
group (defined as 1, white bars). Values are 
mean ± S.E.M. from three independent experiments. 
(*: P < 0.05, one-way ANOVA). (D) PC12 cells 
were subjected to 50 or 100 mV/mm ES for 2 h 
before adding 100 ng/ml NGF for 22 h with or 
without continuous ES. Cell lysates were collected 
and equal amount of proteins was separated by 
SDS-PAGE and immunoblotted with anti-pERK1/2 
and ERK1/2 antibodies. Levels of pERK1/2 were 
normalized to total ERK1/2 levels and compared to 
NGF-only group (defined as 1). PC12 cells were 
subjected to 200 mV/mm ES for 2 h before adding 
50 ng/ml NGF for 22 h with or without continuous 
ES. As a control, PC12 cells were treated with 
50 ng/ml NGF for 22 h. Cell lysates were collected 
and equal amount of proteins was separated by 
SDS-PAGE and immunoblotted with anti-pERK1/2 
and ERK1/2 antibodies. Levels of pERK1/2 were 
normalized to total ERK1/2 levels and compared to 
NGF-only group (defined as 1). (E) PC12 cells were 
subjected to 100 mV/mm ES for 2 h before adding 
100 ng/ml NGF for 2 h with or without ES. Cell 
lysates were collected and equal amount of proteins 
was separated by SDS-PAGE and immunoblotted 
with anti-Egr1 antibody. Relative levels of Egr1 
were normalized to total ERK1/2 levels and 
compared to NGF-only group (defined as 1). 
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Fig. 6. Activated PKC involves in NGF-induced pERK1/2. (A) PC12 cells were pre-treated with or without 162 
nM PMA for 1 h, followed by 100 ng/ml NGF stimulation for 10 min. Cell lysates were collected and equal 
amount of proteins was separated by SDS-PAGE and immunoblotted with anti-pERK1/2 and ERK1/2 antibodies. 
Representative blots are shown from three independent experiments. Levels of pERK1/2 were normalized to 
levels of total ERK1/2 and then compared to NGF-treated group (defined as 1). Values are mean ± S.E.M. (*: 
P < 0.05, one-way ANOVA). (B) PC12 cells were pre-treated with 162 nM PMA or the indicated concentration 
of CHT (chelerythrine) for 1 h, followed by 100 ng/ml NGF stimulation for 10 min. Cell lysates were analyzed 
by western blotting as in (A). The relative level of pERK1/2 was normalized to total ERK1/2 and ratio of 
pERK/ERK was shown at the bottom of the blots. (C) Working model. NGF activates MAPK–ERK1/2 
pathway to induce neuronal differentiation of PC12 cells. ES was previously shown to activate PKC pathway to 
regulate neurite outgrowth. We show that activating PKC by PMA enhances NGF-induced pERK1/2 and likely 
contributes to enhanced neurite outgrowth. 
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